Balfour Beatty (BAFYY) Stock Chart & Stock Price History → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free BAFYY Stock Alerts $10.48 +1.02 (+10.78%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHeadlinesShort InterestStock AnalysisChartDividendHeadlinesShort Interest Balfour Beatty Stock Price Performance5 Day PerformanceN/A1 Month Performance+12.09%3 Month Performance+29.16%6 Month Performance+25.66%Year-To-Date Performance+20.46%1 Year Performance+7.51% Receive BAFYY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Balfour Beatty and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Manward PressThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company BAFYY Stock Chart for Thursday, May, 16, 2024 BAFYY Chart by TradingView Balfour Beatty Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$9.46$10.48+10.83%$10.48$9.897,312 shs$2.78 billion05/14/2024$9.46$9.46$9.46$9.463 shs$2.51 billion05/08/2024$9.46$9.46$9.48$9.461,026 shs$2.51 billion05/07/2024$9.68$9.46-2.31%$9.48$9.461,026 shs$2.51 billion05/03/2024$8.89$8.89$8.89$8.891 shs$2.36 billion04/26/2024$8.89$8.89$8.89$8.891 shs$2.37 billion Get the Latest News and Ratings for BAFYY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Balfour Beatty and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$8.89$8.89$8.89$8.8984 shs$2.37 billion04/24/2024$8.89$8.89$8.89$8.897 shs$2.37 billion04/23/2024$8.89$8.89$8.89$8.898 shs$2.37 billion04/22/2024$8.89$8.89-0.06%$8.89$8.89200 shs$2.37 billion04/19/2024$9.35$8.89-4.97%$8.89$8.89217 shs$2.37 billion04/17/2024$9.35$9.35$9.35$9.352,549 shs$2.50 billion04/16/2024$8.94$9.35+4.59%$9.35$9.352,549 shs$2.50 billion04/12/2024$8.94$8.94$8.94$8.94480 shs$2.39 billion04/11/2024$9.14$8.94-2.19%$8.94$8.94480 shs$2.39 billion04/10/2024$9.65$9.14-5.28%$9.52$8.9028,702 shs$2.44 billion04/09/2024$9.50$9.65+1.58%$10.00$9.5923,100 shs$2.58 billion04/08/2024$9.50$9.50$9.50$9.5035 shs$2.54 billion04/04/2024$9.50$9.50$9.50$9.5056,732 shs$2.54 billion04/03/2024$9.50$9.50$9.50$9.50710 shs$2.54 billion04/02/2024$9.50$9.50$9.50$9.50710 shs$2.54 billion04/01/2024$9.51$9.50-0.05%$9.50$9.50710 shs$2.54 billion03/29/2024$9.51$9.51$9.51$9.5110 shs$2.55 billion03/28/2024$9.51$9.51$9.51$9.513 shs$2.55 billion03/27/2024$9.51$9.51$9.51$9.513 shs$2.55 billion03/26/2024$9.51$9.51$9.51$9.51196 shs$2.55 billion03/25/2024$9.60$9.51-0.99%$9.51$9.51183 shs$2.55 billion03/21/2024$9.60$9.60$9.60$9.59700 shs$2.57 billion03/20/2024$9.70$9.60-1.06%$9.60$9.59700 shs$2.57 billion03/18/2024$9.70$9.70$9.70$9.701,300 shs$2.61 billion03/15/2024$9.52$9.70+1.90%$9.70$9.701,362 shs$2.61 billion03/14/2024$9.78$9.52-2.64%$9.52$9.52502 shs$2.56 billion03/13/2024$9.07$9.78+7.83%$9.78$9.201,633 shs$2.63 billion03/12/2024$9.07$9.07$9.07$9.071 shs$2.44 billion03/11/2024$9.07$9.07$9.07$8.902,500 shs$2.44 billion03/08/2024$8.41$9.07+7.85%$9.07$8.902,583 shs$2.44 billion03/07/2024$8.41$8.41$8.41$8.4140 shs$2.26 billion03/06/2024$8.41$8.41$8.41$8.4140 shs$2.26 billion03/05/2024$8.41$8.41$8.41$8.411 shs$2.26 billion02/26/2024$8.11$8.41+3.65%$8.60$8.41699 shs$2.26 billionHealthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic02/23/2024$8.11$8.11$8.11$8.113 shs$2.19 billion02/16/2024$8.11$8.11$8.11$8.115 shs$2.19 billion Related Companies: PATK Stock Price Chart PRIM Stock Price Chart CCS Stock Price Chart ROCK Stock Price Chart GROUF Stock Price Chart GVA Stock Price Chart FTDR Stock Price Chart DFH Stock Price Chart USLM Stock Price Chart ROAD Stock Price Chart Receive BAFYY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Balfour Beatty and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:BAFYY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsThis unknown company solves the biggest issue with AIManward PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Balfour Beatty plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.